357 related articles for article (PubMed ID: 12534606)
1. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis.
Furue M; Terao H; Rikihisa W; Urabe K; Kinukawa N; Nose Y; Koga T
Br J Dermatol; 2003 Jan; 148(1):128-33. PubMed ID: 12534606
[TBL] [Abstract][Full Text] [Related]
2. Dosage and adverse effects of topical tacrolimus and steroids in daily management of atopic dermatitis.
Furue M; Terao H; Moroi Y; Koga T; Kubota Y; Nakayama J; Furukawa F; Tanaka Y; Katayama I; Kinukawa N; Nose Y; Urabe K
J Dermatol; 2004 Apr; 31(4):277-83. PubMed ID: 15187322
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
5. Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice.
Lübbe J; Friedlander SF; Cribier B; Morren MA; García-Díez A; Gelmetti C; Hofmann H; Houwing RH; Kownacki S; Langley RG; Virtanen M; Wolff K; Wisseh S; McGeown C; Abrams B; Schneider D;
Am J Clin Dermatol; 2006; 7(2):121-31. PubMed ID: 16605292
[TBL] [Abstract][Full Text] [Related]
6. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
7. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
[TBL] [Abstract][Full Text] [Related]
8. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
[TBL] [Abstract][Full Text] [Related]
9. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
Wellington K; Jarvis B
Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
[TBL] [Abstract][Full Text] [Related]
10. Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood.
Queille C; Pommarede R; Saurat JH
Pediatr Dermatol; 1984 Jan; 1(3):246-53. PubMed ID: 6494068
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone proprionate ointments in the treatment of moderate to severe atopic dermatitis in children.
Pei AY; Chan HH; Ho KM
Pediatr Dermatol; 2001; 18(4):343-8. PubMed ID: 11576413
[TBL] [Abstract][Full Text] [Related]
12. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
13. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients.
Hanifin J; Gupta AK; Rajagopalan R
Br J Dermatol; 2002 Sep; 147(3):528-37. PubMed ID: 12207596
[TBL] [Abstract][Full Text] [Related]
14. Epogam evening primrose oil treatment in atopic dermatitis and asthma.
Hederos CA; Berg A
Arch Dis Child; 1996 Dec; 75(6):494-7. PubMed ID: 9014601
[TBL] [Abstract][Full Text] [Related]
15. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse.
Cork MJ; Britton J; Butler L; Young S; Murphy R; Keohane SG
Br J Dermatol; 2003 Sep; 149(3):582-9. PubMed ID: 14510993
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled trial comparing topical steroid application to wet versus dry skin in children with atopic dermatitis (AD).
Kohn LL; Kang Y; Antaya RJ
J Am Acad Dermatol; 2016 Aug; 75(2):306-11. PubMed ID: 27259583
[TBL] [Abstract][Full Text] [Related]
17. Topical steroids for atopic dermatitis in primary care.
Drug Ther Bull; 2003 Jan; 41(1):5-8. PubMed ID: 12611357
[TBL] [Abstract][Full Text] [Related]
18. Do topical steroids reduce relapses in adults with atopic dermatitis?
Williams HC
Arch Dermatol; 1999 Dec; 135(12):1530-1. PubMed ID: 10606062
[No Abstract] [Full Text] [Related]
19. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
Frankel A; Sohn A; Patel RV; Lebwohl M
J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
[TBL] [Abstract][Full Text] [Related]
20. Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use.
Green C; Colquitt JL; Kirby J; Davidson P
Br J Dermatol; 2005 Jan; 152(1):130-41. PubMed ID: 15656813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
